Cardinal Partners
Cardinal Partners is a venture capital partnership focused exclusively on healthcare investing.
Business Model:
Revenue: $15.3M
Employees: 2-10
Rankings
Detailed Cardinal Partners Information
Geographic Data
Address: 230 Nassau St
City: Princeton
State: NJ
Zip: 08542
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
5,316,297Website Global Rank
1,729Website Monthly Traffic
Twitter Followers
Description
[Cardinal Partners](http://www.cardinalpartners.com) is a venture capital partnership focused exclusively on healthcare investing.
Contact Phone:
+16099246452
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2010 | Awarepoint | Series E | 10M |
| 6/2012 | Awarepoint | Venture Round | 14M |
| 12/2008 | Awarepoint | Series D | 13.3M |
| 11/2011 | Medley Health | Series A | 20M |
| 12/2010 | Awarepoint | Venture Round | 9M |
| 6/2002 | IntelliCare | Series B | 10.2M |
| 7/2013 | aTyr Pharma | Series D | 49M |
| 8/2000 | IntelliCare | Venture Round | 7.5M |
| 7/2003 | Alnylam Pharmaceuticals | Private Equity Round | 24.6M |
| 6/2000 | IC-USA | Series B | 9M |
| 5/2015 | lifeIMAGE | Venture Round | 17.6M |
| 9/2014 | Teladoc Health | Equity | 50.3M |
| 1/2011 | lifeIMAGE | Series B | 11.8M |
| 3/2005 | Sirtris Pharmaceuticals | Series B | 27M |
| 6/2006 | Melinta Therapeutics | Series C | 0 |
| 4/2006 | Sirtris Pharmaceuticals | Series C | 37M |
| 4/2007 | aTyr Pharma | Series B | 10.5M |
| 3/2010 | Fluidnet | Series B | 0 |
| 6/2013 | Sapphire Digital | Series C | 0 |
| 9/2017 | Prealize Health | Series A | 6.1M |
| 7/2011 | Verastem Oncology | Series B | 32M |
| 1/2005 | Roving Planet | Series C | 6M |
| 3/2015 | aTyr Pharma | Series E | 76M |
| 12/2005 | CardioOptics | Series B | 20.5M |
| 3/2013 | QPID Health | Series A | 4.4M |
| 9/2011 | Teladoc Health | Series A | 18.6M |
| 2/2017 | Vividion Therapeutics | Series A | 50M |
| 9/2009 | aTyr Pharma | Series C | 12M |
| 11/2011 | Verastem Oncology | Series C | 20M |
| 10/2010 | aTyr Pharma | Series C | 23M |
| 12/2004 | Sirtris Pharmaceuticals | Series A | 13M |
| 3/2006 | CodeRyte | Series C | 0 |
| 9/1999 | Pointshare | Series C | 40M |
| 3/2004 | Momenta Pharmaceuticals | Series C | 20.5M |
| 8/2011 | Awarepoint | Series F | 27M |
| 9/2015 | Ivenix | Venture Round | 0 |
| 4/2007 | Bioconnect Systems | Series A | 8M |
| 12/2011 | lifeIMAGE | Series B | 8.1M |
| 9/2012 | Vascular Pharmaceuticals | Series A | 16M |
| 8/2011 | Fluidnet | Series C | 0 |
| 10/2002 | CardioOptics | Series A | 1.5M |
| 6/2018 | Cureatr | Venture Round | 3M |
| 6/2015 | Cureatr | Series B | 0 |
| 4/2019 | Vividion Therapeutics | Series B | 82M |
| 9/2015 | lifeIMAGE | Series D | 0 |
| 10/2009 | Inspired Technologies | Series B | 0 |
| 9/2014 | Privia Health | Equity | 400M |
| 10/2007 | Inspired Technologies | Series A | 79k |
| 12/2009 | Teladoc Health | Series A | 9M |
| 5/2003 | Momenta Pharmaceuticals | Series B | 19M |
| 10/2013 | Cureatr | Series A | 5.7M |
| 12/2007 | AxoGen | Post-IPO Equity | 12.1M |
| 11/2008 | CodeRyte | Series D | 0 |
| 2/1999 | Pointshare | Series B | 7.3M |
| 4/2016 | Vividion Therapeutics | Series A | 3.5M |
| 11/2010 | Verastem Oncology | Series A | 16M |
| 4/2013 | lifeIMAGE | Series C | 15.2M |
| 11/2002 | NexCura | Series C | 4M |
| 4/2019 | Vividion Therapeutics | Series B | 0 |
| 6/2018 | Cureatr | Venture Round | 0 |
| 9/2017 | Prealize Health | Series A | 0 |
| 2/2017 | Vividion Therapeutics | Series A | 0 |
| 4/2016 | Vividion Therapeutics | Series A | 0 |
| 9/2015 | lifeIMAGE | Series D | 0 |
| 9/2015 | Ivenix | Venture Round | 0 |
| 6/2015 | Cureatr | Series B | 0 |
| 5/2015 | lifeIMAGE | Venture Round | 0 |
| 3/2015 | aTyr Pharma | Series E | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
